Compile Data Set for Download or QSAR

Found 3301 hits with Last Name = 'venkatesan' and Initial = 'h'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50415081 (CHEMBL571650) Show SMILES OC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1ccc(Br)cc1NS(=O)(=O)c1cccc2nccnc12 |r| Show InChI InChI=1S/C24H17Br2FN4O5S/c25-14-5-6-15(23(32)30-20(24(33)34)11-13-4-7-17(27)16(26)10-13)19(12-14)31-37(35,36)21-3-1-2-18-22(21)29-9-8-28-18/h1-10,12,20,31H,11H2,(H,30,32)(H,33,34)/t20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	5.01	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50415082 (CHEMBL583035) Show SMILES OC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1ccc(I)cc1NS(=O)(=O)c1cccc2nsnc12 |r| Show InChI InChI=1S/C22H15BrFIN4O5S2/c23-14-8-11(4-7-15(14)24)9-18(22(31)32)26-21(30)13-6-5-12(25)10-17(13)29-36(33,34)19-3-1-2-16-20(19)28-35-27-16/h1-8,10,18,29H,9H2,(H,26,30)(H,31,32)/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	5.01	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50415080 (CHEMBL585157) Show SMILES OC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1ccc(Br)cc1NS(=O)(=O)c1cccc2nsnc12 |r| Show InChI InChI=1S/C22H15Br2FN4O5S2/c23-12-5-6-13(21(30)26-18(22(31)32)9-11-4-7-15(25)14(24)8-11)17(10-12)29-36(33,34)19-3-1-2-16-20(19)28-35-27-16/h1-8,10,18,29H,9H2,(H,26,30)(H,31,32)/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	6.31	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50415083 (CHEMBL566574) Show SMILES OC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1cc(Cl)c(Cl)cc1NS(=O)(=O)c1cccc2nccnc12 |r| Show InChI InChI=1S/C24H16BrCl2FN4O5S/c25-14-8-12(4-5-17(14)28)9-20(24(34)35)31-23(33)13-10-15(26)16(27)11-19(13)32-38(36,37)21-3-1-2-18-22(21)30-7-6-29-18/h1-8,10-11,20,32H,9H2,(H,31,33)(H,34,35)/t20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	6.31	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50415078 (CHEMBL565298) Show SMILES OC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1ccc(Cl)cc1NS(=O)(=O)c1cccc2nsnc12 |r| Show InChI InChI=1S/C22H15BrClFN4O5S2/c23-14-8-11(4-7-15(14)25)9-18(22(31)32)26-21(30)13-6-5-12(24)10-17(13)29-36(33,34)19-3-1-2-16-20(19)28-35-27-16/h1-8,10,18,29H,9H2,(H,26,30)(H,31,32)/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	10	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50415084 (CHEMBL565324) Show SMILES OC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1cc(Cl)c(Cl)cc1NS(=O)(=O)c1cccc2nsnc12 |r| Show InChI InChI=1S/C22H14BrCl2FN4O5S2/c23-12-6-10(4-5-15(12)26)7-18(22(32)33)27-21(31)11-8-13(24)14(25)9-17(11)30-37(34,35)19-3-1-2-16-20(19)29-36-28-16/h1-6,8-9,18,30H,7H2,(H,27,31)(H,32,33)/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	10	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50415079 (CHEMBL569391) Show SMILES OC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1ccc(Cl)cc1NS(=O)(=O)c1cccc2nccnc12 |r| Show InChI InChI=1S/C24H17BrClFN4O5S/c25-16-10-13(4-7-17(16)27)11-20(24(33)34)30-23(32)15-6-5-14(26)12-19(15)31-37(35,36)21-3-1-2-18-22(21)29-9-8-28-18/h1-10,12,20,31H,11H2,(H,30,32)(H,33,34)/t20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	10	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50415077 (CHEMBL584525) Show SMILES OC(=O)[C@H](Cc1ccc(Cl)c(Br)c1)NC(=O)c1ccc(Br)cc1NS(=O)(=O)c1cccc2nccnc12 |r| Show InChI InChI=1S/C24H17Br2ClN4O5S/c25-14-5-6-15(23(32)30-20(24(33)34)11-13-4-7-17(27)16(26)10-13)19(12-14)31-37(35,36)21-3-1-2-18-22(21)29-9-8-28-18/h1-10,12,20,31H,11H2,(H,30,32)(H,33,34)/t20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	10	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50415085 (CHEMBL570520) Show SMILES OC(=O)[C@H](Cc1ccc(Cl)c(Br)c1)NC(=O)c1ccc(Br)cc1NS(=O)(=O)c1cccc2nsnc12 |r| Show InChI InChI=1S/C22H15Br2ClN4O5S2/c23-12-5-6-13(21(30)26-18(22(31)32)9-11-4-7-15(25)14(24)8-11)17(10-12)29-36(33,34)19-3-1-2-16-20(19)28-35-27-16/h1-8,10,18,29H,9H2,(H,26,30)(H,31,32)/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	12.6	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50415066 (CHEMBL585914) Show SMILES OC(=O)[C@H](Cc1ccc(Cl)c(Cl)c1)NC(=O)c1ccc(Cl)cc1NS(=O)(=O)c1cccc2nsnc12 |r| Show InChI InChI=1S/C22H15Cl3N4O5S2/c23-12-5-6-13(21(30)26-18(22(31)32)9-11-4-7-14(24)15(25)8-11)17(10-12)29-36(33,34)19-3-1-2-16-20(19)28-35-27-16/h1-8,10,18,29H,9H2,(H,26,30)(H,31,32)/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	15.8	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50415076 (CHEMBL583344) Show SMILES OC(=O)[C@H](Cc1ccc(Cl)c(Cl)c1)NC(=O)c1ccc(I)cc1NS(=O)(=O)c1cccc2nsnc12 |r| Show InChI InChI=1S/C22H15Cl2IN4O5S2/c23-14-7-4-11(8-15(14)24)9-18(22(31)32)26-21(30)13-6-5-12(25)10-17(13)29-36(33,34)19-3-1-2-16-20(19)28-35-27-16/h1-8,10,18,29H,9H2,(H,26,30)(H,31,32)/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	25.1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50415077 (CHEMBL584525) Show SMILES OC(=O)[C@H](Cc1ccc(Cl)c(Br)c1)NC(=O)c1ccc(Br)cc1NS(=O)(=O)c1cccc2nccnc12 |r| Show InChI InChI=1S/C24H17Br2ClN4O5S/c25-14-5-6-15(23(32)30-20(24(33)34)11-13-4-7-17(27)16(26)10-13)19(12-14)31-37(35,36)21-3-1-2-18-22(21)29-9-8-28-18/h1-10,12,20,31H,11H2,(H,30,32)(H,33,34)/t20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50415085 (CHEMBL570520) Show SMILES OC(=O)[C@H](Cc1ccc(Cl)c(Br)c1)NC(=O)c1ccc(Br)cc1NS(=O)(=O)c1cccc2nsnc12 |r| Show InChI InChI=1S/C22H15Br2ClN4O5S2/c23-12-5-6-13(21(30)26-18(22(31)32)9-11-4-7-15(25)14(24)8-11)17(10-12)29-36(33,34)19-3-1-2-16-20(19)28-35-27-16/h1-8,10,18,29H,9H2,(H,26,30)(H,31,32)/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	126	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50415083 (CHEMBL566574) Show SMILES OC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1cc(Cl)c(Cl)cc1NS(=O)(=O)c1cccc2nccnc12 |r| Show InChI InChI=1S/C24H16BrCl2FN4O5S/c25-14-8-12(4-5-17(14)28)9-20(24(34)35)31-23(33)13-10-15(26)16(27)11-19(13)32-38(36,37)21-3-1-2-18-22(21)30-7-6-29-18/h1-8,10-11,20,32H,9H2,(H,31,33)(H,34,35)/t20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	158	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50415082 (CHEMBL583035) Show SMILES OC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1ccc(I)cc1NS(=O)(=O)c1cccc2nsnc12 |r| Show InChI InChI=1S/C22H15BrFIN4O5S2/c23-14-8-11(4-7-15(14)24)9-18(22(31)32)26-21(30)13-6-5-12(25)10-17(13)29-36(33,34)19-3-1-2-16-20(19)28-35-27-16/h1-8,10,18,29H,9H2,(H,26,30)(H,31,32)/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	158	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50415084 (CHEMBL565324) Show SMILES OC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1cc(Cl)c(Cl)cc1NS(=O)(=O)c1cccc2nsnc12 |r| Show InChI InChI=1S/C22H14BrCl2FN4O5S2/c23-12-6-10(4-5-15(12)26)7-18(22(32)33)27-21(31)11-8-13(24)14(25)9-17(11)30-37(34,35)19-3-1-2-16-20(19)29-36-28-16/h1-6,8-9,18,30H,7H2,(H,27,31)(H,32,33)/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	158	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50415076 (CHEMBL583344) Show SMILES OC(=O)[C@H](Cc1ccc(Cl)c(Cl)c1)NC(=O)c1ccc(I)cc1NS(=O)(=O)c1cccc2nsnc12 |r| Show InChI InChI=1S/C22H15Cl2IN4O5S2/c23-14-7-4-11(8-15(14)24)9-18(22(31)32)26-21(30)13-6-5-12(25)10-17(13)29-36(33,34)19-3-1-2-16-20(19)28-35-27-16/h1-8,10,18,29H,9H2,(H,26,30)(H,31,32)/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	200	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50415075 (CHEMBL566177) Show SMILES COC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1cc(Cl)c(Cl)cc1NS(=O)(=O)c1cccc2nccnc12 |r| Show InChI InChI=1S/C25H18BrCl2FN4O5S/c1-38-25(35)21(10-13-5-6-18(29)15(26)9-13)32-24(34)14-11-16(27)17(28)12-20(14)33-39(36,37)22-4-2-3-19-23(22)31-8-7-30-19/h2-9,11-12,21,33H,10H2,1H3,(H,32,34)/t21-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	200	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50415080 (CHEMBL585157) Show SMILES OC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1ccc(Br)cc1NS(=O)(=O)c1cccc2nsnc12 |r| Show InChI InChI=1S/C22H15Br2FN4O5S2/c23-12-5-6-13(21(30)26-18(22(31)32)9-11-4-7-15(25)14(24)8-11)17(10-12)29-36(33,34)19-3-1-2-16-20(19)28-35-27-16/h1-8,10,18,29H,9H2,(H,26,30)(H,31,32)/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	251	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50415078 (CHEMBL565298) Show SMILES OC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1ccc(Cl)cc1NS(=O)(=O)c1cccc2nsnc12 |r| Show InChI InChI=1S/C22H15BrClFN4O5S2/c23-14-8-11(4-7-15(14)25)9-18(22(31)32)26-21(30)13-6-5-12(24)10-17(13)29-36(33,34)19-3-1-2-16-20(19)28-35-27-16/h1-8,10,18,29H,9H2,(H,26,30)(H,31,32)/t18-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	251	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50415075 (CHEMBL566177) Show SMILES COC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1cc(Cl)c(Cl)cc1NS(=O)(=O)c1cccc2nccnc12 |r| Show InChI InChI=1S/C25H18BrCl2FN4O5S/c1-38-25(35)21(10-13-5-6-18(29)15(26)9-13)32-24(34)14-11-16(27)17(28)12-20(14)33-39(36,37)22-4-2-3-19-23(22)31-8-7-30-19/h2-9,11-12,21,33H,10H2,1H3,(H,32,34)/t21-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	251	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-2R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50415081 (CHEMBL571650) Show SMILES OC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1ccc(Br)cc1NS(=O)(=O)c1cccc2nccnc12 |r| Show InChI InChI=1S/C24H17Br2FN4O5S/c25-14-5-6-15(23(32)30-20(24(33)34)11-13-4-7-17(27)16(26)10-13)19(12-14)31-37(35,36)21-3-1-2-18-22(21)29-9-8-28-18/h1-10,12,20,31H,11H2,(H,30,32)(H,33,34)/t20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	316	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50415079 (CHEMBL569391) Show SMILES OC(=O)[C@H](Cc1ccc(F)c(Br)c1)NC(=O)c1ccc(Cl)cc1NS(=O)(=O)c1cccc2nccnc12 |r| Show InChI InChI=1S/C24H17BrClFN4O5S/c25-16-10-13(4-7-17(16)27)11-20(24(33)34)30-23(32)15-6-5-14(26)12-19(15)31-37(35,36)21-3-1-2-18-22(21)29-9-8-28-18/h1-10,12,20,31H,11H2,(H,30,32)(H,33,34)/t20-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	398	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]-CCK-8S from human CCK-1R after 100 mins by liquid scintillation counting				Bioorg Med Chem Lett 19: 6376-8 (2009) Article DOI: 10.1016/j.bmcl.2009.09.065 BindingDB Entry DOI: 10.7270/Q2X92CJK
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196208 (1-[2-[(2,1,3-benzothiadiazol-5-ylsulfonyl)amino]-4...) Show SMILES Brc1ccc(C(=O)N2CCCCC2)c(NS(=O)(=O)c2ccc3nsnc3c2)c1 Show InChI InChI=1S/C18H17BrN4O3S2/c19-12-4-6-14(18(24)23-8-2-1-3-9-23)16(10-12)22-28(25,26)13-5-7-15-17(11-13)21-27-20-15/h4-7,10-11,22H,1-3,8-9H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196209 (1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...) Show SMILES Clc1cc(NS(=O)(=O)c2cccc3nsnc23)c(cc1Cl)C(=O)N1CCCCC1 Show InChI InChI=1S/C18H16Cl2N4O3S2/c19-12-9-11(18(25)24-7-2-1-3-8-24)15(10-13(12)20)23-29(26,27)16-6-4-5-14-17(16)22-28-21-14/h4-6,9-10,23H,1-3,7-8H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196210 (1-[4-bromo-2-[(5-quinoxalinylsulfonyl)amino]benzoy...) Show SMILES Brc1ccc(C(=O)N2CCCCC2)c(NS(=O)(=O)c2cccc3nccnc23)n1 Show InChI InChI=1S/C19H18BrN5O3S/c20-16-8-7-13(19(26)25-11-2-1-3-12-25)18(23-16)24-29(27,28)15-6-4-5-14-17(15)22-10-9-21-14/h4-10H,1-3,11-12H2,(H,23,24)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196200 (1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...) Show SMILES O=C(N1CCCCC1)c1ccc(cc1NS(=O)(=O)c1cccc2nsnc12)-n1cccc1 Show InChI InChI=1S/C22H21N5O3S2/c28-22(27-13-2-1-3-14-27)17-10-9-16(26-11-4-5-12-26)15-19(17)25-32(29,30)20-8-6-7-18-21(20)24-31-23-18/h4-12,15,25H,1-3,13-14H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196201 (1-[2-[7-bromo(2,1,3-benzothiadiazol-4-ylsulfonyl)a...) Show SMILES Brc1ccc(C(=O)N2CCCCC2)c(NS(=O)(=O)c2ccc(Br)c3nsnc23)c1 Show InChI InChI=1S/C18H16Br2N4O3S2/c19-11-4-5-12(18(25)24-8-2-1-3-9-24)14(10-11)23-29(26,27)15-7-6-13(20)16-17(15)22-28-21-16/h4-7,10,23H,1-3,8-9H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50196184 (1-[3-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...) Show SMILES Clc1ccc(cc1NS(=O)(=O)c1cccc2nsnc12)C(=O)N1CCCCC1 Show InChI InChI=1S/C18H17ClN4O3S2/c19-13-8-7-12(18(24)23-9-2-1-3-10-23)11-15(13)22-28(25,26)16-6-4-5-14-17(16)21-27-20-14/h4-8,11,22H,1-3,9-10H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK2R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196202 (1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...) Show SMILES [O-][N+](=O)c1ccc(C(=O)N2CCCCC2)c(NS(=O)(=O)c2cccc3nsnc23)c1 Show InChI InChI=1S/C18H17N5O5S2/c24-18(22-9-2-1-3-10-22)13-8-7-12(23(25)26)11-15(13)21-30(27,28)16-6-4-5-14-17(16)20-29-19-14/h4-8,11,21H,1-3,9-10H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50196185 (1-[2-[(2,1,3-benzothiadiazol-4-ylcarbonyl)amino]-4...) Show SMILES Brc1ccc(C(=O)N2CCCCC2)c(NC(=O)c2cccc3nsnc23)c1 Show InChI InChI=1S/C19H17BrN4O2S/c20-12-7-8-13(19(26)24-9-2-1-3-10-24)16(11-12)21-18(25)14-5-4-6-15-17(14)23-27-22-15/h4-8,11H,1-3,9-10H2,(H,21,25)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK2R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50196216 (1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-b...) Show SMILES O=C(N1CCCCC1)c1ccccc1NS(=O)(=O)c1cccc2nsnc12 Show InChI InChI=1S/C18H18N4O3S2/c23-18(22-11-4-1-5-12-22)13-7-2-3-8-14(13)21-27(24,25)16-10-6-9-15-17(16)20-26-19-15/h2-3,6-10,21H,1,4-5,11-12H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK2R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196212 (1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...) Show SMILES O=C(N1CCCCC1)C1=C(CC(NCc2ccccc2)C=C1)NS(=O)(=O)c1cccc2nsnc12 |c:22,t:9| Show InChI InChI=1S/C25H27N5O3S2/c31-25(30-14-5-2-6-15-30)20-13-12-19(26-17-18-8-3-1-4-9-18)16-22(20)29-35(32,33)23-11-7-10-21-24(23)28-34-27-21/h1,3-4,7-13,19,26,29H,2,5-6,14-17H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196207 (1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...) Show SMILES Clc1ccc(C(=O)N2CCCCCC2)c(NS(=O)(=O)c2cccc3nsnc23)c1 Show InChI InChI=1S/C19H19ClN4O3S2/c20-13-8-9-14(19(25)24-10-3-1-2-4-11-24)16(12-13)23-29(26,27)17-7-5-6-15-18(17)22-28-21-15/h5-9,12,23H,1-4,10-11H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196213 (1-[4-bromo-2-[5-fluoro(2,1,3-benzothiadiazol-4-yls...) Show SMILES Fc1ccc2nsnc2c1S(=O)(=O)Nc1cc(Br)ccc1C(=O)N1CCCCC1 Show InChI InChI=1S/C18H16BrFN4O3S2/c19-11-4-5-12(18(25)24-8-2-1-3-9-24)15(10-11)23-29(26,27)17-13(20)6-7-14-16(17)22-28-21-14/h4-7,10,23H,1-3,8-9H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196206 (1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...) Show SMILES Clc1ccc(C(=O)N2CCCC2)c(NS(=O)(=O)c2cccc3nsnc23)c1 Show InChI InChI=1S/C17H15ClN4O3S2/c18-11-6-7-12(17(23)22-8-1-2-9-22)14(10-11)21-27(24,25)15-5-3-4-13-16(15)20-26-19-13/h3-7,10,21H,1-2,8-9H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196219 ((R)-4-[4-chloro-2-[(5-quinoxalinylsulfonyl)amino]b...) Show SMILES C[C@@H]1COCCN1C(=O)c1ccc(Cl)cc1NS(=O)(=O)c1cccc2nccnc12 Show InChI InChI=1S/C20H19ClN4O4S/c1-13-12-29-10-9-25(13)20(26)15-6-5-14(21)11-17(15)24-30(27,28)18-4-2-3-16-19(18)23-8-7-22-16/h2-8,11,13,24H,9-10,12H2,1H3/t13-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196211 (1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-6...) Show SMILES Clc1cccc(NS(=O)(=O)c2cccc3nsnc23)c1C(=O)N1CCCCC1 Show InChI InChI=1S/C18H17ClN4O3S2/c19-12-6-4-7-13(16(12)18(24)23-10-2-1-3-11-23)22-28(25,26)15-9-5-8-14-17(15)21-27-20-14/h4-9,22H,1-3,10-11H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50196152 (1-[4-chloro-2-[(quinolin-8-ylsulfonyl)amino]-benzo...) Show SMILES Clc1ccc(C(=O)N2CCCCC2)c(NS(=O)(=O)c2cccc3cccnc23)c1 Show InChI InChI=1S/C21H20ClN3O3S/c22-16-9-10-17(21(26)25-12-2-1-3-13-25)18(14-16)24-29(27,28)19-8-4-6-15-7-5-11-23-20(15)19/h4-11,14,24H,1-3,12-13H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK2R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50196161 (1-[4-acetylamino-2-[(2,1,3-benzothiadiazol-4-ylsul...) Show SMILES CC(=O)Nc1ccc(C(=O)N2CCCCC2)c(NS(=O)(=O)c2cccc3nsnc23)c1 Show InChI InChI=1S/C20H21N5O4S2/c1-13(26)21-14-8-9-15(20(27)25-10-3-2-4-11-25)17(12-14)24-31(28,29)18-7-5-6-16-19(18)23-30-22-16/h5-9,12,24H,2-4,10-11H2,1H3,(H,21,26)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK2R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196215 (1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...) Show SMILES Brc1cc(NS(=O)(=O)c2cccc3nsnc23)c(cc1Br)C(=O)N1CCCCC1 Show InChI InChI=1S/C18H16Br2N4O3S2/c19-12-9-11(18(25)24-7-2-1-3-8-24)15(10-13(12)20)23-29(26,27)16-6-4-5-14-17(16)22-28-21-14/h4-6,9-10,23H,1-3,7-8H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196214 ((3R,5S)-rel-4-[4-chloro-2-[(5-quinoxalinylsulfonyl...) Show SMILES C[C@H]1COC[C@@H](C)N1C(=O)c1ccc(Cl)cc1NS(=O)(=O)c1cccc2nccnc12 Show InChI InChI=1S/C21H21ClN4O4S/c1-13-11-30-12-14(2)26(13)21(27)16-7-6-15(22)10-18(16)25-31(28,29)19-5-3-4-17-20(19)24-9-8-23-17/h3-10,13-14,25H,11-12H2,1-2H3/t13-,14+	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196220 (1-[4-bromo-2-[5-methyl(2,1,3-benzothiadiazol-4-yls...) Show SMILES Cc1ccc2nsnc2c1S(=O)(=O)Nc1cc(Br)ccc1C(=O)N1CCCCC1 Show InChI InChI=1S/C19H19BrN4O3S2/c1-12-5-8-15-17(22-28-21-15)18(12)29(26,27)23-16-11-13(20)6-7-14(16)19(25)24-9-3-2-4-10-24/h5-8,11,23H,2-4,9-10H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196217 (1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...) Show SMILES CCc1ccc(C(=O)N2CCCCC2)c(NS(=O)(=O)c2cccc3nsnc23)c1 Show InChI InChI=1S/C20H22N4O3S2/c1-2-14-9-10-15(20(25)24-11-4-3-5-12-24)17(13-14)23-29(26,27)18-8-6-7-16-19(18)22-28-21-16/h6-10,13,23H,2-5,11-12H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196218 (1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...) Show SMILES CN(C)c1ccc(C(=O)N2CCCCC2)c(NS(=O)(=O)c2cccc3nsnc23)c1 Show InChI InChI=1S/C20H23N5O3S2/c1-24(2)14-9-10-15(20(26)25-11-4-3-5-12-25)17(13-14)23-30(27,28)18-8-6-7-16-19(18)22-29-21-16/h6-10,13,23H,3-5,11-12H2,1-2H3	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196153 (1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...) Show SMILES Clc1ccc(C(=O)N2CCC(CC2)N2CCCCC2)c(NS(=O)(=O)c2cccc3nsnc23)c1 Show InChI InChI=1S/C23H26ClN5O3S2/c24-16-7-8-18(23(30)29-13-9-17(10-14-29)28-11-2-1-3-12-28)20(15-16)27-34(31,32)21-6-4-5-19-22(21)26-33-25-19/h4-8,15,17,27H,1-3,9-14H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Gastrin/cholecystokinin type B receptor (Homo sapiens (Human))	BDBM50196172 (1-[4-bromo-2-[[naphthalen-1-ylsulfonyl]amino]benzo...) Show SMILES Brc1ccc(C(=O)N2CCCCC2)c(NS(=O)(=O)c2cccc3ccccc23)c1 Show InChI InChI=1S/C22H21BrN2O3S/c23-17-11-12-19(22(26)25-13-4-1-5-14-25)20(15-17)24-29(27,28)21-10-6-8-16-7-2-3-9-18(16)21/h2-3,6-12,15,24H,1,4-5,13-14H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK2R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196149 (4-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]be...) Show SMILES O=C(N1CCOCC1)c1ccccc1NS(=O)(=O)c1cccc2nsnc12 Show InChI InChI=1S/C17H16N4O4S2/c22-17(21-8-10-25-11-9-21)12-4-1-2-5-13(12)20-27(23,24)15-7-3-6-14-16(15)19-26-18-14/h1-7,20H,8-11H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196150 (4-[4-fluoro-2-[(5-quinoxalinylsulfonyl)amino]benzo...) Show SMILES Fc1ccc(C(=O)N2CCOCC2)c(NS(=O)(=O)c2cccc3nccnc23)c1 Show InChI InChI=1S/C19H17FN4O4S/c20-13-4-5-14(19(25)24-8-10-28-11-9-24)16(12-13)23-29(26,27)17-3-1-2-15-18(17)22-7-6-21-15/h1-7,12,23H,8-11H2	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair
Cholecystokinin receptor type A (Homo sapiens (Human))	BDBM50196151 ((3S,5S)-4-[4-chloro-2-[(5-quinoxalinylsulfonyl)ami...) Show SMILES C[C@H]1COC[C@H](C)N1C(=O)c1ccc(Cl)cc1NS(=O)(=O)c1cccc2nccnc12 Show InChI InChI=1S/C21H21ClN4O4S/c1-13-11-30-12-14(2)26(13)21(27)16-7-6-15(22)10-18(16)25-31(28,29)19-5-3-4-17-20(19)24-9-8-23-17/h3-10,13-14,25H,11-12H2,1-2H3/t13-,14-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Johnson and Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Displacement of [125I]CCK-8S from human CCK1R				J Med Chem 49: 6371-90 (2006) Article DOI: 10.1021/jm060590x BindingDB Entry DOI: 10.7270/Q2MK6CHM
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 3301 total )  |  Next  |  Last  >>

Jump to: